Correction: Profiling HPV-16–specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients
Kunal H. Bhatt(QIMR Berghofer Medical Research Institute), Rajiv Khanna(QIMR Berghofer Medical Research Institute), Sandro Porceddu(Peter MacCallum Cancer Centre), Corey Smith(QIMR Berghofer Medical Research Institute), Sriganesh Srihari(QIMR Berghofer Medical Research Institute), Lea Lekieffre(QIMR Berghofer Medical Research Institute), Howard Liu(Princess Alexandra Hospital), Liz Kenny(Palo Alto University), Pauline Crooks(QIMR Berghofer Medical Research Institute), Michelle A. Neller(QIMR Berghofer Medical Research Institute), Blake T. Aftab(Unknown)
Cited by 1
Related Papers
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
|Journal of Clinical Oncology|2006|543
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.
|The Journal of Experimental Medicine|1992|391
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
|Journal of Clinical Oncology|2010|372
Activation and adoptive transfer of Epstein–Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease
|Proceedings of the National Academy of Sciences|1999|332